Interim study to examine the role of health insurance for biomarker testing and the use of biomarker testing in public and private payor markets
2024/04/05 Referred to Banking, Commerce and Insurance Committee
Interim study to examine the role of health insurance for biomarker testing and the use of biomarker testing in public and private payor markets
2024/04/05 Referred to Banking, Commerce and Insurance Committee